Upstream Cell Line Development
-
What Researchers Should Look For When Choosing A CLD Partner
11/7/2025
A strong track record in compliant saline production and scalable quality is key when selecting a biomanufacturing partner. See how these factors help ensure regulatory alignment and long-term success.
-
VIPS™ For Cell Therapy: Updates
9/30/2022
Watch to learn about the latest developments to VIPS™ which address the needs of cell therapy companies moving towards GMP manufacturing.
-
SF-RVN® Platform For Improving The Safety Profile Of Your Therapies
7/19/2022
Discover how our Insect Cell Line provides a high performance platform optimal to produce recombinant proteins, viral vaccines, and adeno-associated vectors (AAV) for gene therapy applications.
-
A Collaboration With Zurich University Of Applied Sciences
5/19/2025
Explore ZHAW’s pioneering work and collaboration in cell cultivation and bioprocessing to deliver scalable, high-performance solutions that address key challenges in biomanufacturing scale-up.
-
STUDIUS™ & ICON™: Data-Driven Workflow For The Development Of Modern Cell-Based Therapies
2/28/2022
Learn how these two new products work to provide a new data-driven workflow for the development of modern cell-based therapies.
-
Navigating The Workflow From Process Development To GMP Manufacturing For Making Clonal iPSC-Derived Master Cell Banks
3/7/2022
In this video, we present data for optimizing choices of which combinations of GMP-compatible matrix, dissociation reagents, and media can best be employed for single cell cloning of iPSCs in process development.
-
The STUDIUS™ Powered Ecosystem
9/30/2022
Watch to learn about the latest updates to the Solentim portfolio of products providing solutions to optimize your processes and increase confidence in your work.
-
How Biologic Therapeutics Are Developed
8/26/2021
Scientists are harnessing the power of cellular machinery to produce therapeutic biologics that can target specific conditions. Learn about the process of developing a biologic treatment.